CN1610663A - Process for producing azetidinone compounds - Google Patents
Process for producing azetidinone compounds Download PDFInfo
- Publication number
- CN1610663A CN1610663A CNA03801808XA CN03801808A CN1610663A CN 1610663 A CN1610663 A CN 1610663A CN A03801808X A CNA03801808X A CN A03801808XA CN 03801808 A CN03801808 A CN 03801808A CN 1610663 A CN1610663 A CN 1610663A
- Authority
- CN
- China
- Prior art keywords
- group
- metal atom
- periodic table
- general formula
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
技术领域technical field
本发明涉及作为碳青霉烯类化合物的重要合成中间体的氮杂环丁酮化合物。The present invention relates to an azetidinone compound as an important synthetic intermediate of carbapenem compounds.
背景技术Background technique
制备重要的抗菌物质1β-甲基碳青霉烯类(カルバペネム)衍生物时使用的4位侧链的1’位具有β-甲基的氮杂环丁酮化合物的重要合成中间体(3S,4R)-3-[(R)-1-羟基乙基]-4-[(R)-1-甲基-3-重氮基-3-取代的氧羰基-2-氧代-丙基]-氮杂环丁烷-2-酮[A]:An important synthetic intermediate of the azetidinone compound (3S, 4R)-3-[(R)-1-Hydroxyethyl]-4-[(R)-1-methyl-3-diazo-3-substituted oxycarbonyl-2-oxo-propyl] -Azetidin-2-one[A]:
[式中,R表示烷基、可以具有取代基的苄基、可以具有取代基的芳基。][wherein, R represents an alkyl group, a benzyl group which may have a substituent, or an aryl group which may have a substituent. ]
的制备方法,已知例如有特开昭57-123182号公报记载的下述反应路线1:The preparation method of is known, for example, the following reaction scheme 1 described in JP-A No. 57-123182:
所表示的制备方法;特开昭64-25779号公报记载的下述反应路线2:Represented preparation method; the following reaction scheme 2 of JP-A No. 64-25779 communique record:
表示的制备法;特开平6-321946号公报记载的下述反应路线3:The preparation method of expression; The following reaction scheme 3 that the Japanese Patent Application Publication No. 6-321946 records:
表示的制备方法;以及特开昭58-103358号公报、特开平6-199780号公报、特开昭61-275284号公报记载的下述反应路线4:The preparation method shown; and the following reaction scheme 4 recorded in the Japanese Patent Application No. 58-103358, the Japanese Patent Application No. 6-199780, and the Japanese Publication No. 61-275284:
表示的制备方法等。Indicates the preparation method, etc.
但是,这些制备方法均具有以下所述的问题,不能说充分进行。However, these production methods all have the problems described below, and cannot be said to perform sufficiently.
即,在反应路线1~3的方法中,使用高价的起始原料,并且因工序数多而使得操作麻烦,无论是收率还是价格均不理想。That is, in the methods of reaction schemes 1 to 3, expensive starting materials are used, and the operation is troublesome due to a large number of steps, and neither the yield nor the price is ideal.
另外,在反应路线4的方法中,通过比较短的工序制备,但由于必须使用不稳定的甲硅烷烯醇醚,因此难以说是工业的方法,并且也难以说是经济的方法。In addition, in the method of Reaction scheme 4, it is prepared through a relatively short process, but since an unstable silyl enol ether must be used, it is difficult to say that it is an industrial method, and it is also difficult to say that it is an economical method.
发明的公开disclosure of invention
本发明的目的是解决上述的现有方法存在的问题,提供在温和的条件下、工序短、收率好、并且选择性地得到所需的在1’-β位具有甲基的碳青霉烯类抗菌剂的合成中间体的方法。The purpose of the present invention is to solve the problems in the above-mentioned existing methods, provide under mild conditions, short steps, good yield, and selectively obtain the required carbapenicillium having a methyl group at the 1'-β position A method for the synthesis of intermediates of vinyl antibacterial agents.
本发明涉及通式[1]表示的化合物:The present invention relates to compounds represented by general formula [1]:
(式中,R1、R2、R3和X与下同。)(In the formula, R 1 , R 2 , R 3 and X are the same as below.)
的制备方法,其特征在于,The preparation method is characterized in that,
使下面通式[2]表示的化合物:Make the compound represented by the following general formula [2]:
(式中,R1表示氢原子或羟基保护基,L表示离去基团)(In the formula, R 1 represents a hydrogen atom or a hydroxyl protecting group, and L represents a leaving group)
与下面通式[3]表示的化合物:With the compound represented by the following general formula [3]:
(式中,R2表示氢原子或碳数为1~4的低级烷基,R3表示碳数为1~12的烷基、可以具有取代基的苯基、可以具有取代基的碳数为7~15的芳烷基、或者可以具有取代基的5~8员环的脂环基,X表示氧原子或硫原子)(In the formula, R 2 represents a hydrogen atom or a lower alkyl group with a carbon number of 1 to 4, R 3 represents an alkyl group with a carbon number of 1 to 12, a phenyl group that may have a substituent, and a carbon number that may have a substituent is 7-15 aralkyl groups, or 5-8 membered ring alicyclic groups that may have substituents, X represents an oxygen atom or a sulfur atom)
在下面通式[4]:In the following general formula [4]:
MYn(R4)m (4)MY n (R 4 ) m (4)
(式中,M表示金属原子,Y表示卤素原子,R4表示碳数为1~4的低级烷基、碳数为1~4的低级烷氧基、可以具有取代基的苯氧基、烷基磺酰二氧基、芳磺酰二氧基、烷基磺酰氧基、芳磺酰氧基、环戊二烯基、或者五甲基环戊二烯基,n和m为0~4的整数,并且n+m为M的原子价)(In the formula, M represents a metal atom, Y represents a halogen atom, R4 represents a lower alkyl group with 1 to 4 carbons, a lower alkoxy group with 1 to 4 carbons, a phenoxy group that may have a substituent, an alkane group, etc. Sulfonyldioxy, arylsulfonyldioxy, alkylsulfonyloxy, arylsulfonyloxy, cyclopentadienyl, or pentamethylcyclopentadienyl, n and m are 0 to 4 integer, and n+m is the atomic valence of M)
表示的金属化合物及碱的存在下发生反应。The reaction occurs in the presence of the indicated metal compound and a base.
即,本发明人为达到上述目的进行了努力研究,结果发现,仅通过使上面通式[2]表示的化合物与上面通式[3]表示的重氮化合物在特定的金属化合物和碱的存在下进行反应,就可以选择性地且收率良好地制备所需的具有1’-β构型的氮杂环丁酮化合物[1],从而完成了本发明。That is, the present inventors have conducted diligent research to achieve the above object, and as a result found that only by making the compound represented by the above general formula [2] and the diazo compound represented by the above general formula [3] in the presence of a specific metal compound and a base By carrying out the reaction, the desired azetidinone compound [1] having the 1'-β configuration can be produced selectively and in good yield, thereby completing the present invention.
本发明提供不必将重氮化合物变换为甲硅烷烯醇醚,仅通过使上面通式[2]表示的化合物与上面通式[3]表示的重氮化合物在特定的金属化合物和碱的存在下进行反应,就可以在温和的条件下选择性地制备所需的具有1’-β构型的氮杂环丁酮化合物[1]的方法,该方法工序短、收率好。The present invention provides that it is not necessary to convert the diazo compound into a silyl enol ether, only by making the compound represented by the above general formula [2] and the diazo compound represented by the above general formula [3] in the presence of a specific metal compound and a base By carrying out the reaction, the desired azetidinone compound [1] with 1'-β configuration can be selectively prepared under mild conditions, and the method has short steps and good yield.
实施发明的最佳方式The best way to practice the invention
在本发明的制备方法中使用的前述通式[2]表示的化合物中,作为R1表示的羟基保护基,例如列举肽化学和β-内酰胺化合物的领域中通常使用的所有羟基保护基。In the compound represented by the aforementioned general formula [2] used in the production method of the present invention, examples of the hydroxyl protecting group represented by R include all hydroxyl protecting groups commonly used in the fields of peptide chemistry and β-lactam compounds.
即,例如,三甲基甲硅烷基、三乙基甲硅烷基、三异丙基甲硅烷基、二甲基异丙基甲硅烷基、二乙基异丙基甲硅烷基、二甲基(2,3-二甲基-2-丁基)甲硅烷基、叔丁基二甲基甲硅烷基、二甲基己基甲硅烷基等的三(碳数为1~6的烷基)甲硅烷基,例如二甲基异丙苯基甲硅烷基等的二(碳数为1~6的烷基)-碳数为6~18的芳基-甲硅烷基,例如叔丁基二苯基甲硅烷基、二苯基甲基甲硅烷基等的二(碳数为6~18的芳基)-碳数为1~6的烷基-甲硅烷基,例如三苯基甲硅烷基等的三(碳数为6~18的芳基)甲硅烷基,例如三苄基甲硅烷基、三(对二甲苯基)甲硅烷基等的三(碳数为7~19的芳烷基)甲硅烷基等的三取代的甲硅烷基;例如苄基、4-甲氧基苄基、2-硝基苄基、4-硝基苄基、二苯基甲基、三苯基甲基等的可以由碳数为1~4的烷氧基(例如甲氧基、乙氧基)或硝基等取代其1~3个氢原子的碳数为7~19的芳烷基;例如,甲氧羰基、乙氧羰基、叔丁氧羰基、2,2,2-三氯乙氧羰基、2-三甲基甲硅烷基乙氧基羰基等的可以由碳数为1~4的烷氧基(例如甲氧基、乙氧基)或卤素原子(例如氟、氯、溴、碘等)、或者三(碳数为1~4的烷基)甲硅烷基(例如三甲基甲硅烷基)等取代其1~3个氢原子的碳数为1~6的烷氧羰基;例如,苄氧羰基、2-硝基苄氧羰基、4-硝基苄氧羰基、4-甲氧基苄氧羰基、3,4-二甲氧基苄基氧羰基等的可以由碳数为1~4的烷氧基(例如甲氧基、乙氧基等)或者硝基取代其1~3个氢原子的碳数为7~10的芳烷基氧羰基;例如,乙烯基氧羰基、烯丙基氧羰基等的碳数为2~6的链烯基氧羰基;例如,甲酰基、乙酰基、氯乙酰基、二氯乙酰基、三氯乙酰基、三氟乙酰基、丙酰基、丁酰基、苯甲酰基、4-甲苯甲酰基、4-甲氧苯酰基、4-硝基苯甲酰基等的可以由卤素原子(例如氟、氯、溴、碘等)或硝基等取代其1~3个氢原子的酰基;例如四氢吡喃基、四氢呋喃基等的环状保护基等。That is, for example, trimethylsilyl, triethylsilyl, triisopropylsilyl, dimethylisopropylsilyl, diethylisopropylsilyl, dimethyl( 2,3-Dimethyl-2-butyl)silyl, tert-butyldimethylsilyl, dimethylhexylsilyl and other tri(alkyl with 1 to 6 carbons)silyl group, such as dimethyl cumyl silyl and other di(alkyl with 1 to 6 carbons)-aryl-silyl with 6 to 18 carbons, such as tert-butyldiphenylmethyl Di(aryl with 6 to 18 carbons)-alkyl-silyl with 1 to 6 carbons, such as silyl and diphenylmethylsilyl, such as triphenylsilyl, etc. (Aryl)silyl groups with 6 to 18 carbons, such as tris(arylalkyls with 7 to 19 carbons)silyls such as tribenzylsilyl and tri(p-xylyl)silyl Trisubstituted silyl groups such as benzyl, 4-methoxybenzyl, 2-nitrobenzyl, 4-nitrobenzyl, diphenylmethyl, triphenylmethyl, etc. can be An aralkyl group with 7 to 19 carbons whose 1 to 3 hydrogen atoms are replaced by an alkoxy group with 1 to 4 carbons (such as methoxy, ethoxy) or nitro; for example, methoxycarbonyl , ethoxycarbonyl, tert-butoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 2-trimethylsilylethoxycarbonyl, etc. can be composed of alkoxy groups with 1 to 4 carbons (such as methoxy, ethoxy) or halogen atoms (such as fluorine, chlorine, bromine, iodine, etc.), or three (alkyl with 1 to 4 carbons) silyl groups (such as trimethylsilyl) etc. An alkoxycarbonyl group having 1 to 6 carbon atoms in 1 to 3 hydrogen atoms; for example, benzyloxycarbonyl, 2-nitrobenzyloxycarbonyl, 4-nitrobenzyloxycarbonyl, 4-methoxybenzyloxycarbonyl, 3,4-dimethoxybenzyloxycarbonyl, etc., whose carbon number of 1 to 3 hydrogen atoms can be replaced by an alkoxy group with a carbon number of 1 to 4 (such as methoxy, ethoxy, etc.) or a nitro group Aralkyloxycarbonyl with a number of 7 to 10; for example, alkenyloxycarbonyl with a carbon number of 2 to 6 such as vinyloxycarbonyl and allyloxycarbonyl; for example, formyl, acetyl, chloroacetyl , dichloroacetyl, trichloroacetyl, trifluoroacetyl, propionyl, butyryl, benzoyl, 4-toluoyl, 4-methoxybenzoyl, 4-nitrobenzoyl, etc. can be derived from Halogen atom (such as fluorine, chlorine, bromine, iodine, etc.) or acyl group in which 1 to 3 hydrogen atoms are replaced by a nitro group; ring protecting groups such as tetrahydropyranyl, tetrahydrofuranyl, etc.
这些保护基中优选例如碳数为7~19的芳烷基氧羰基(例如苄氧羰基、4-硝基苄氧羰基等)、碳数为2~6的链烯基氧羰基(例如烯丙基氧羰基)、三(碳数为1~6的烷基)甲硅烷基等,更优选叔丁基二甲基甲硅烷基等。Preferred among these protecting groups are, for example, aralkyloxycarbonyl groups with 7 to 19 carbons (such as benzyloxycarbonyl, 4-nitrobenzyloxycarbonyl, etc.), alkenyloxycarbonyls with 2 to 6 carbons (such as allyl oxycarbonyl), tri(alkyl having 1 to 6 carbons) silyl and the like, more preferably tert-butyldimethylsilyl and the like.
另外,L表示的离去基团例如有酰氧基(例如,烷酰氧基、芳酰氧基、芳基烷酰氧基、烷基磺酰氧基、芳基磺酰氧基、烷氧羰基氧基、芳烷氧羰基氧基、烷氧基烷酰氧基、氨基甲酰基氧基等)、烷酰硫基、芳酰硫基、烷硫基、芳硫基、烷基亚磺酰基、芳基亚磺酰基、烷基磺酰基、芳基磺酰基、卤原子等。In addition, the leaving group represented by L includes, for example, acyloxy (for example, alkanoyloxy, aroyloxy, arylalkanoyloxy, alkylsulfonyloxy, arylsulfonyloxy, alkoxy carbonyloxy, aralkoxycarbonyloxy, alkoxyalkanoyloxy, carbamoyloxy, etc.), alkanoylthio, aroylthio, alkylthio, arylthio, alkylsulfinyl , arylsulfinyl group, alkylsulfonyl group, arylsulfonyl group, halogen atom, etc.
作为L是烷酰氧基时的具体例子,可以列举乙酰氧基、丙酰氧基、丁酰氧基、α-氟乙酰氧基、α-氯乙酰氧基、α-溴乙酰氧基、α-碘乙酰氧基、α,α-二氟乙酰氧基、α,α-二氯乙酰氧基、α-氰基乙酰氧基等的可以由1~3个卤素、氰基等取代基取代的直链烷酰氧基、异丁酰氧基、环己基羰氧基等的支链或环状烷酰氧基等。Specific examples of when L is an alkanoyloxy group include acetyloxy, propionyloxy, butyryloxy, α-fluoroacetoxy, α-chloroacetoxy, α-bromoacetoxy, α -Iodoacetoxy, α,α-difluoroacetoxy, α,α-dichloroacetoxy, α-cyanoacetoxy, etc. may be substituted by 1 to 3 substituents such as halogen, cyano, etc. branched or cyclic alkanoyloxy groups such as straight-chain alkanoyloxy, isobutyryloxy, cyclohexylcarbonyloxy, and the like.
作为L是芳酰氧基时的具体例子,可以列举苯甲酰氧基、1-萘甲酰氧基、2-萘甲酰氧基、烟酰氧基、异烟酰氧基、糠酰氧基(フルフロイルオキシ)等的可以具有杂原子的单环或多环芳酰氧基。Specific examples of when L is an aroyloxy group include benzoyloxy, 1-naphthoyloxy, 2-naphthoyloxy, nicotinoyloxy, isonicotinoyloxy, furoyloxy A monocyclic or polycyclic aroyloxy group which may have a heteroatom, such as a group (Frufroyruokeshi).
作为L是芳基烷酰氧基时的具体例子,可以列举苯基乙酰氧基等。Specific examples of when L is an arylalkanoyloxy group include phenylacetoxy and the like.
作为L是烷基磺酰氧基时的具体例子,可以列举甲磺酰氧基、乙磺酰氧基、丙磺酰氧基、三氟甲磺酰氧基等。Specific examples of when L is an alkylsulfonyloxy group include methanesulfonyloxy, ethanesulfonyloxy, propanesulfonyloxy, trifluoromethanesulfonyloxy and the like.
作为L是芳基磺酰基时的具体例子,可以列举苯磺酰氧基、对甲苯磺酰氧基等。Specific examples of when L is an arylsulfonyl group include benzenesulfonyloxy, p-toluenesulfonyloxy and the like.
作为L是烷氧羰基氧基时的具体例子,可以列举甲氧羰基氧基、乙氧羰基氧基等。Specific examples of when L is an alkoxycarbonyloxy group include methoxycarbonyloxy, ethoxycarbonyloxy and the like.
作为L是芳烷氧羰基氧基时的具体例子,可以列举苄氧羰基氧基等。Specific examples of when L is aralkoxycarbonyloxy include benzyloxycarbonyloxy and the like.
作为L是烷氧基烷酰氧基时的具体例子,可以列举甲氧基乙酰氧基、乙氧基乙酰氧基等。Specific examples of when L is an alkoxyalkanoyloxy group include methoxyacetoxy, ethoxyacetoxy and the like.
作为L是氨基甲酰氧基时的具体例子,可以列举N-甲基氨基甲酰氧基、N-乙基氨基甲酰氧基、N-苯基氨基甲酰氧基等。Specific examples of when L is a carbamoyloxy group include N-methylcarbamoyloxy, N-ethylcarbamoyloxy, N-phenylcarbamoyloxy and the like.
作为L是烷酰硫基时的具体例子,可以列举乙酰硫基、丙酰硫基等。Specific examples of when L is an alkanoylthio group include acetylthio, propionylthio and the like.
作为L是芳酰硫基时的具体例子,可以列举苯甲酰硫基、萘甲酰硫基等。Specific examples of when L is an aroylthio group include benzoylthio, naphthoylthio and the like.
作为L是烷硫基时的具体例子,可以列举甲硫基、乙硫基、正丙硫基、异丙硫基、正丁硫基、异丁硫基、叔丁硫基等。Specific examples of when L is an alkylthio group include methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, tert-butylthio and the like.
作为L是芳硫基时的具体例子,可以列举苯硫基、萘硫基等。Specific examples of when L is an arylthio group include phenylthio, naphthylthio and the like.
作为L是烷基亚磺酰基时的具体例子,可以列举甲亚磺酰基、乙亚磺酰基、正丙亚磺酰基、正丁亚磺酰基等。Specific examples of when L is an alkylsulfinyl group include methanesulfinyl, ethanesulfinyl, n-propylsulfinyl, n-butylsulfinyl and the like.
作为L是芳基亚磺酰基时的具体例子,可以列举苯亚磺酰基、对甲苯亚磺酰基等。Specific examples of when L is an arylsulfinyl group include phenylsulfinyl, p-toluenesulfinyl and the like.
作为L是烷基磺酰基时的具体例子,可以列举甲磺酰基、乙磺酰基、正丙磺酰基、正丁磺酰基等。Specific examples of when L is an alkylsulfonyl group include methylsulfonyl, ethylsulfonyl, n-propanesulfonyl, n-butanesulfonyl and the like.
作为L是芳基磺酰基时的具体例子,可以列举苯磺酰基、对甲苯磺酰基等。Specific examples of when L is an arylsulfonyl group include benzenesulfonyl, p-toluenesulfonyl and the like.
作为L是卤素原子时的具体例子,可以列举氟、氯、溴、碘等。Specific examples of when L is a halogen atom include fluorine, chlorine, bromine, iodine and the like.
这些离去基团中,特别优选乙酰氧基等。Among these leaving groups, acetoxy group and the like are particularly preferable.
本发明的制备方法中使用的前述通式[3]表示的化合物中,作为R2表示的碳数为1~4的低级烷基的具体例子,可以列举甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基等。Among the compounds represented by the aforementioned general formula [3] used in the production method of the present invention, specific examples of lower alkyl groups having 1 to 4 carbon atoms represented by R include methyl, ethyl, n-propyl, Isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, etc.
另外,作为优选的R2,可以列举氢原子或甲基。Moreover, a hydrogen atom or a methyl group is mentioned as preferable R2 .
在通式[3]中,作为R3表示的碳数为1~12的烷基的具体例子,可以列举甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基、戊基、己基、庚基、辛基、壬基、癸基、十一烷基、十二烷基等。In the general formula [ 3 ], specific examples of the alkyl group having 1 to 12 carbon atoms represented by R include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, Sec-butyl, tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, etc.
作为R3表示的碳数为2~5的链烯基的具体例子,可以列举乙烯基、烯丙基、1-丙烯基、异丙烯基、1-丁烯基、2-丁烯基、2-甲基烯丙基等。Specific examples of alkenyl groups having 2 to 5 carbon atoms represented by R3 include vinyl, allyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 2-butenyl, and 2-butenyl. - Methallyl etc.
作为R3表示的可以有取代基的苯基的取代基,可以列举碳数为1~4的低级烷基、碳数为1~4的低级烷氧基、硝基、卤素原子等。Examples of substituents for the optionally substituted phenyl group represented by R3 include lower alkyl groups having 1 to 4 carbon atoms, lower alkoxy groups having 1 to 4 carbon atoms, nitro groups, and halogen atoms.
此时,作为取代基的碳数为1~4的低级烷基的具体例子,可以列举甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基等。另外,作为碳数为1~4的低级烷氧基的具体例子,可以列举甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基、异丁氧基、仲丁氧基、叔丁氧基等。作为卤素原子的具体例子,可以列举氟、氯、溴、碘等。In this case, specific examples of the lower alkyl group having 1 to 4 carbon atoms as the substituent include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t- Butyl, etc. In addition, specific examples of lower alkoxy groups having 1 to 4 carbon atoms include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butyl Oxygen, tert-butoxy, etc. Specific examples of the halogen atom include fluorine, chlorine, bromine, iodine and the like.
作为R3表示的可以有取代基的碳数为7~15的芳烷基的取代基,可以列举碳数为1~4的低级烷基、碳数为1~4的低级烷氧基、硝基、卤素原子等。As the substituent of an aralkyl group having 7 to 15 carbons that may have a substituent represented by R , examples include lower alkyls with 1 to 4 carbons, lower alkoxyls with 1 to 4 carbons, nitric acid, etc. groups, halogen atoms, etc.
此时,作为取代基的碳数为1~4的低级烷基的具体例子,可以列举甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基等。另外,作为碳数为1~4的低级烷氧基的具体例子,可以列举甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基、异丁氧基、仲丁氧基、叔丁氧基等。另外,作为卤素原子的具体例子,可以列举氟、氯、溴、碘等。In this case, specific examples of the lower alkyl group having 1 to 4 carbon atoms as the substituent include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, t- Butyl, etc. In addition, specific examples of lower alkoxy groups having 1 to 4 carbon atoms include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butyl Oxygen, tert-butoxy, etc. In addition, specific examples of the halogen atom include fluorine, chlorine, bromine, iodine and the like.
另外,作为可以有取代基的碳数为7~15的芳烷基的具体例子,可以列举苄基、α-苯乙基、β-苯乙基、α-苯丙基、β-苯丙基、γ-苯丙基、萘甲基等。In addition, specific examples of an aralkyl group having 7 to 15 carbon atoms that may have a substituent include benzyl, α-phenylethyl, β-phenylethyl, α-phenylpropyl, β-phenylpropyl , γ-phenylpropyl, naphthylmethyl, etc.
作为R3表示的可以有取代基的5~8员环的脂环基的具体例子,可以列举环戊基、环己基、环庚基、环辛基等。另外,作为取代基,可以列举甲基、乙基、丙基、异丙基、丁基、异丁基、仲丁基、叔丁基等碳数为1~4的低级烷基。Specific examples of the optionally substituted 5- to 8-membered alicyclic group represented by R3 include cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. In addition, examples of the substituent include lower alkyl groups having 1 to 4 carbon atoms such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, and tert-butyl.
其中,作为特别优选的R3,可以例举甲基、乙基、丙基、异丙基、丁基、叔丁基等碳数为1~4的低级烷基;苄基、对硝基苄基、对甲氧基苄基等可以具有取代基(硝基、甲氧基等)的碳数为7~15的芳烷基;乙烯基、烯丙基等碳数为2~5的链烯基等。Among them, as particularly preferable R 3 , lower alkyl groups having 1 to 4 carbon atoms such as methyl, ethyl, propyl, isopropyl, butyl, and tert-butyl; benzyl, p-nitrobenzyl; Aralkyl groups with 7 to 15 carbons that may have substituents (nitro, methoxy, etc.) such as p-methoxybenzyl, p-methoxybenzyl; alkenes with 2 to 5 carbons such as vinyl and allyl Base etc.
本发明的制备方法中使用的前述通式[4]表示的金属化合物中,作为M表示的金属原子,可以列举有机合成化学、碳-碳键生成反应等中一般使用的金属原子,更具体地,例如,钛、锆等IUPAC的周期表第4族的金属;硅、锡等IUPAC周期表第14族的金属;硼、铝(アルニウム)等IUPAC周期表第13族的金属;钪、钇、镧系元素(镧、铈、镨、钕、钐、钆、镝、铒、镱)等周期表第3族的金属;铁、钌等周期表第8族的金属;锌等周期表第12族的金属等。In the metal compound represented by the aforementioned general formula [4] used in the production method of the present invention, the metal atom represented by M includes metal atoms generally used in organic synthesis chemistry, carbon-carbon bond formation reaction, etc., more specifically For example, metals of Group 4 of the periodic table of IUPAC such as titanium and zirconium; metals of Group 14 of the periodic table of IUPAC such as silicon and tin; metals of Group 13 of the periodic table of IUPAC such as boron and aluminum; scandium, yttrium, Metals of group 3 of the periodic table such as lanthanides (lanthanum, cerium, praseodymium, neodymium, samarium, gadolinium, dysprosium, erbium, ytterbium); metals of group 8 of the periodic table such as iron and ruthenium; metals of group 12 of the periodic table such as zinc metal etc.
通式[4]中,Y表示的卤素原子可以列举氟原子、氯原子、溴原子、碘原子等。In the general formula [4], examples of the halogen atom represented by Y include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
通式[4]中,作为R4表示的碳数为1~4的低级烷基的具体例子,可以列举甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基等,另外,作为碳数为1~4的低级烷氧基的具体例子,可以列举甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基、异丁氧基、仲丁氧基、叔丁氧基等。In the general formula [ 4 ], specific examples of lower alkyl groups having 1 to 4 carbon atoms represented by R include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, etc., and specific examples of lower alkoxy groups having 1 to 4 carbon atoms include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy base, isobutoxy, sec-butoxy, tert-butoxy, etc.
另外,作为R4表示的可以具有取代基的苯氧基的取代基,可以列举碳数为1~4的低级烷基、碳数为1~4的低级烷氧基、卤素原子等。In addition, examples of substituents for the optionally substituted phenoxy group represented by R include lower alkyl groups having 1 to 4 carbon atoms, lower alkoxy groups having 1 to 4 carbon atoms, and halogen atoms .
这里,作为取代基的碳数为1~4的低级烷基的具体例子,可以列举甲基、乙基、正丙基、异丙基、正丁基、异丁基、仲丁基、叔丁基等,另外,作为碳数为1~4的低级烷氧基的具体例子,可以列举甲氧基、乙氧基、正丙氧基、异丙氧基、正丁氧基、异丁氧基、仲丁氧基、叔丁氧基等,另外,作为卤素原子的具体例子,可以列举氟、氯、溴、碘等。Here, specific examples of the lower alkyl group having 1 to 4 carbon atoms as the substituent include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl In addition, specific examples of lower alkoxy groups having 1 to 4 carbon atoms include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, and isobutoxy , sec-butoxy, tert-butoxy, etc., and specific examples of the halogen atom include fluorine, chlorine, bromine, iodine, and the like.
作为R4表示的烷基磺酰二氧基的具体例子,可以列举,甲磺酰二氧基、乙磺酰二氧基、三氟甲磺酰二氧基等。Specific examples of the alkylsulfonyldioxy group represented by R include methanesulfonyldioxy, ethanesulfonyldioxy, trifluoromethanesulfonyldioxy and the like.
作为R4表示的芳基磺酰二氧基的具体例子,可以列举,苯磺酰二氧基、对甲苯磺酰二氧基等。Specific examples of the arylsulfonyldioxy group represented by R include benzenesulfonyldioxy, p-toluenesulfonyldioxy, and the like.
作为R4表示的烷基磺酰氧基的具体例子,可以列举甲磺酰氧基、乙磺酰氧基、三氟甲磺酰氧基等。Specific examples of the alkylsulfonyloxy group represented by R include methanesulfonyloxy, ethanesulfonyloxy, trifluoromethanesulfonyloxy and the like.
作为R4表示的芳基磺酰氧基的具体例子,可以列举苯磺酰氧基、对甲苯磺酰氧基等。Specific examples of the arylsulfonyloxy group represented by R include benzenesulfonyloxy, p-toluenesulfonyloxy, and the like.
作为通式[2]表示的化合物的制备方法,没有特别的限定,例如可以通过J.Am.Chem.Soc.,112卷,7820~7822页(1990)、TetrahedronLetters,32卷,2145~2148页(1991)、Tetrahedron Letters,32卷,5991~5994页(1991)等中记载的方法或依照这些方法的方法加以合成。The method for producing the compound represented by the general formula [2] is not particularly limited, for example, J.Am.Chem.Soc., volume 112, pages 7820-7822 (1990), Tetrahedron Letters, volume 32, pages 2145-2148 (1991), Tetrahedron Letters, volume 32, pages 5991 to 5994 (1991), etc., or synthesized according to the methods described in these methods.
作为通式[2]表示的化合物的具体例子,可以列举Specific examples of the compound represented by the general formula [2] include
4-乙酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Acetoxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-乙酰氧基-3-[1-叔丁基二苯基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Acetoxy-3-[1-tert-butyldiphenylsilyloxyethyl]-azetidin-2-one,
4-乙酰氧基-3-[1-三乙基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Acetoxy-3-[1-triethylsilyloxyethyl]-azetidin-2-one,
4-乙酰氧基-3-[1-三甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Acetoxy-3-[1-trimethylsilyloxyethyl]-azetidin-2-one,
4-乙酰氧基-3-[1-二甲基癸基(テキシル)甲硅烷基氧乙基]-氮杂环丁烷-2-酮,4-Acetoxy-3-[1-dimethyldecyl (Teksil) silyloxyethyl]-azetidin-2-one,
4-乙酰氧基-3-[1-羟乙基乙基]-氮杂环丁烷-2-酮,4-Acetoxy-3-[1-hydroxyethylethyl]-azetidin-2-one,
4-α-氯乙酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-α-Chloroacetoxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-异丁酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-isobutyryloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-丙酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-propionyloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-苯甲酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Benzoyloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-对甲苯硫基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-p-Tolylthio-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-苯硫基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Phenylthio-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-对甲苯亚磺酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-p-Toluenesulfinyloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-苯亚磺酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Benzenesulfinyloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-对甲苯磺酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-p-Toluenesulfonyloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-苯磺酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Benzenesulfonyloxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-氯-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Chloro-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-溴-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-Bromo-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-碘-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮,4-iodo-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one,
4-氰基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮等。4-cyano-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one and the like.
作为这些化合物中的优选化合物,可以列举例如,4-乙酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮和4-α-氯乙酰氧基-3-[1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮等。As preferred compounds among these compounds, for example, 4-acetoxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one and 4- α-Chloroacetoxy-3-[1-tert-butyldimethylsilyloxyethyl]-azetidin-2-one and the like.
作为通式[3]表示的重氮化合物的制备方法,没有特别的限定,但例如可以通过特开昭58-103385号公报、特开昭61-275284号公报所记载的方法或根据这些方法的方法进行合成。The preparation method of the diazo compound represented by the general formula [3] is not particularly limited, but for example, the method described in JP-A-58-103385 A, JP-A-61-275284 A, or according to these methods can be used. method for synthesis.
作为通式[3]表示的重氮化合物的具体例子,可以列举例如,Specific examples of the diazo compound represented by the general formula [3] include, for example,
2-重氮基-3-氧代丁酸甲酯2-diazo-3-oxobutanoic acid methyl ester
2-重氮基-3-氧代戊酸甲酯Methyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸甲酯Methyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸乙酯2-diazo-3-oxobutanoic acid ethyl ester
2-重氮基-3-氧代戊酸乙酯Ethyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸乙酯Ethyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸正丙酯n-Propyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸正丙酯n-Propyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸正丙酯n-Propyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸异丙酯Isopropyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸异丙酯Isopropyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸异丙酯Isopropyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸正丁酯n-Butyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸正丁酯n-Butyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸正丁酯n-Butyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸叔丁酯tert-butyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸叔丁酯tert-Butyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸叔丁酯tert-butyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸苄酯Benzyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸苄酯Benzyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸苄酯Benzyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸对硝基苄酯2-diazo-3-oxobutanoic acid p-nitrobenzyl ester
2-重氮基-3-氧代戊酸对硝基苄酯2-diazo-3-oxopentanoic acid p-nitrobenzyl ester
2-重氮基-3-氧代己酸对硝基苄酯2-diazo-3-oxohexanoic acid p-nitrobenzyl ester
2-重氮基-3-氧代丁酸对甲氧基苄酯2-diazo-3-oxobutanoic acid p-methoxybenzyl ester
2-重氮基-3-氧代戊酸对甲氧基苄酯2-diazo-3-oxopentanoic acid p-methoxybenzyl ester
2-重氮基-3-氧代己酸对甲氧基苄酯2-diazo-3-oxohexanoic acid p-methoxybenzyl ester
2-重氮基-3-氧代丁酸乙烯酯Vinyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸乙烯酯Vinyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸乙烯酯Vinyl 2-diazo-3-oxohexanoate
2-重氮基-3-氧代丁酸烯丙酯Allyl 2-diazo-3-oxobutanoate
2-重氮基-3-氧代戊酸烯丙酯Allyl 2-diazo-3-oxopentanoate
2-重氮基-3-氧代己酸烯丙酯Allyl 2-diazo-3-oxohexanoate
等。wait.
作为这些化合物中的优选化合物,例如可以列举2-重氮基-3-氧代戊酸叔丁酯、2-重氮基-3-氧代戊酸苄酯、2-重氮基-3-氧代戊酸对硝基苄酯、2-重氮基-3-氧代戊酸烯丙酯等。Preferred compounds among these compounds include, for example, tert-butyl 2-diazo-3-oxopentanoate, benzyl 2-diazo-3-oxopentanoate, 2-diazo-3- p-nitrobenzyl oxopentanoate, allyl 2-diazo-3-oxopentanoate, and the like.
本发明中使用的通式[4]表示的金属化合物可以以市售品直接使用,根据需要可以对其进行提纯。The metal compound represented by the general formula [4] used in the present invention can be used as it is as a commercial item, and can be purified as necessary.
作为通式[4]表示的金属化合物的具体例子,例如,可以列举,TiCl4、TiCl3(OCH3)、TiCl3(OC2H5)、TiCl3(O-正丙基)、TiCl3(O-异丙基)、TiCl3(O-丁基)、TiCl3(O-异丁基)、TiCl3(O-仲丁基)、TiCl3(O-叔丁基)、TiCl2(O-甲基)2、TiCl2(O-乙基)2、TiCl2(O-正丙基)2、TiCl2(O-异丙基)2、TiCl2(O-丁基)2、TiCl2(O-异丁基)2、TiCl2(O-仲丁基)2、TiCl2(O-叔丁基)2、Ti(Cp)2Cl2、Ti(Cp*)2Cl2、TiBr4、TiI4等的钛化合物;ZnCl2、ZnBr2、ZnI2等的锌化合物;ZrCl4、ZrCl3(O-甲基)、ZrCl3(O-乙基)、ZrCl3(O-正丙基)、ZrCl3(O-异丙基)、ZrCl3(O-正丁基)、ZrCl3(O-异丁基)、ZrCl3(O-仲丁基)、ZrCl3(O-叔丁基)、Zr(Cp)2Cl2、Zr(Cp*)2Cl2、ZrBr4、ZrI4等的锆化合物;AlCl3、Al(O-甲基)3、Al(O-乙基)3、Al(O-正丙基)3、Al(O-异丙基)3、AlCl2Me、AlClMe2、AlMe3、AlCl2Et、AlClEt2、AlEt3、AlBr3、AlI3等的铝化合物;SnCl4、SnBr4、SnI4、Sn(OSO2CF3)2等的锡化合物;FeCl3、FeBr3、FeI3等的铁化合物;(C2H5)2O·BF3、(CH3)2BOSO2CF3、(C2H5)2BOSO2CF3、(Pr)2BOSO2CF3、(Bu)2BOSO2CF3等的硼化合物;(CH3)3SiOSO2CF3、(CH3)3SiCl等的硅化合物;ScF3、ScCl3、ScBr3、ScI3、Sc(O-异丙基)3、Sc(OSO2CH3)3等的钪化合物;YF3、YCl3、YBr3、YI3、Y(O-异丙基)3、Y(OSO2CH3)3等的钇化合物;LaF3、LaCl3、LaBr3、LaI3、La(O-异丙基)3、La(OSO2CH3)3等的镧化合物;CeF3、CeCl3、CeBr3、CeI3、Ce(O-异丙基)3、Ce(OSO2CH3)3等的铈化合物;PrF3、PrCl3、PrBr3、PrI3、Pr(O-异丙基)3、Pr(OSO2CH3)3等的镨化合物;NdF3、NdCl3、NdBr3、NdI3、Nd(O-异丙基)3、Nd(OSO2CH3)3等的钕化合物;SmF3、SmCl3、SmBr3、SmI3、Sm(O-异丙基)3、Sm(OSO2CH3)3等的钐化合物;GdF3、GdCl3、GdBr3、GdI3、Gd(O-异丙基)3、Gd(OSO2CH3)3等的钆化合物;DyF3、DyCl3、DyBr3、DyI3、Dy(O-异丙基)3、Dy(OSO2CH3)3等的镝化合物;ErF3、ErCl3、ErBr3、ErI3、Er(O-异丙基)3、Er(OSO2CH3)3等的铒化合物;YbF3、YbCl3、YbBr3、YbI3、Yb(O-异丙基)3、Yb(OSO2CH3)3等的镱化合物等。Specific examples of the metal compound represented by the general formula [4] include, for example, TiCl 4 , TiCl 3 (OCH 3 ), TiCl 3 (OC 2 H 5 ), TiCl 3 (O-n-propyl), TiCl 3 (O-isopropyl), TiCl 3 (O-butyl), TiCl 3 (O-isobutyl), TiCl 3 (O-sec-butyl), TiCl 3 (O-tert-butyl), TiCl 2 ( O-methyl) 2 , TiCl 2 (O-ethyl) 2 , TiCl 2 (O-n-propyl) 2 , TiCl 2 (O-isopropyl) 2 , TiCl 2 (O-butyl) 2 , TiCl 2 (O-isobutyl) 2 , TiCl 2 (O-sec-butyl) 2 , TiCl 2 (O-tert-butyl) 2 , Ti(Cp) 2 Cl 2 , Ti(Cp * ) 2 Cl 2 , TiBr 4. Titanium compounds such as TiI 4 ; zinc compounds such as ZnCl 2 , ZnBr 2 , ZnI 2 , etc.; ZrCl 4 , ZrCl 3 (O-methyl), ZrCl 3 (O-ethyl), ZrCl 3 (O-n-propyl base), ZrCl 3 (O-isopropyl), ZrCl 3 (O-n-butyl), ZrCl 3 (O-isobutyl), ZrCl 3 (O-sec-butyl), ZrCl 3 (O-tert-butyl base), Zr(Cp) 2 Cl 2 , Zr(Cp * ) 2 Cl 2 , ZrBr 4 , ZrI 4 and other zirconium compounds; AlCl 3 , Al(O-methyl) 3 , Al(O-ethyl) 3 , Al(O-n-propyl) 3 , Al(O-isopropyl) 3 , AlCl 2 Me, AlClMe 2 , AlMe 3 , AlCl 2 Et, AlClEt 2 , AlEt 3 , AlBr 3 , AlI 3 and other aluminum compounds ; tin compounds such as SnCl 4 , SnBr 4 , SnI 4 , Sn(OSO 2 CF 3 ) 2, etc.; iron compounds such as FeCl 3 , FeBr 3 , FeI 3 , etc.; (C 2 H 5 ) 2 O·BF 3 , (CH 3 ) Boron compounds of 2 BOSO 2 CF 3 , (C 2 H 5 ) 2 BOSO 2 CF 3 , (Pr) 2 BOSO 2 CF 3 , (Bu) 2 BOSO 2 CF 3 , etc.; (CH 3 ) 3 SiOSO 2 CF 3. Silicon compounds such as (CH 3 ) 3 SiCl; scandium compounds such as ScF 3 , ScCl 3 , ScBr 3 , ScI 3 , Sc(O-isopropyl) 3 , Sc(OSO 2 CH 3 ) 3 ; YF 3 , YCl 3 , YBr 3 , YI 3 , Y(O-isopropyl) 3 , Y(OSO 2 CH 3 ) 3 and other yttrium compounds; LaF 3 , LaCl 3 , LaBr 3 , LaI 3 , La(O-isopropyl) Lanthanum compounds such as propyl) 3 , La(OSO 2 CH 3 ) 3 ; CeF 3 , CeCl 3 , CeBr 3 , CeI 3 , Ce(O-isopropyl) 3 , Ce(OSO 2 CH 3 ) 3 Cerium compounds; PrF 3 , PrCl 3 , PrBr 3 , PrI 3 , Pr(O-isopropyl) 3 , Pr(OSO 2 CH 3 ) 3 and other praseodymium compounds; NdF 3 , NdCl 3 , NdBr 3 , NdI 3 , Neodymium compounds of Nd(O-isopropyl) 3 , Nd(OSO 2 CH 3 ) 3 , etc.; SmF 3 , SmCl 3 , SmBr 3 , SmI 3 , Sm(O-isopropyl) 3 , Sm(OSO 2 CH 3 ) Samarium compounds such as 3 ; gadolinium compounds such as GdF 3 , GdCl 3 , GdBr 3 , GdI 3 , Gd(O-isopropyl) 3 , Gd(OSO 2 CH 3 ) 3 ; DyF 3 , DyCl 3 , DyBr 3. DyI 3 , Dy(O-isopropyl) 3 , Dy(OSO 2 CH 3 ) 3 and other dysprosium compounds; ErF 3 , ErCl 3 , ErBr 3 , ErI 3 , Er(O-isopropyl) 3 , Erbium compounds such as Er(OSO 2 CH 3 ) 3 ; Ytterbium compounds such as YbF 3 , YbCl 3 , YbBr 3 , YbI 3 , Yb(O-isopropyl) 3 , Yb(OSO 2 CH 3 ) 3 , etc.
另外,上述的Cp表示环戊二烯基,Cp*表示五甲基环戊二烯基。In addition, the above-mentioned Cp represents a cyclopentadienyl group, and Cp * represents a pentamethylcyclopentadienyl group.
这些金属化合物中更优选TiCl4(四氯化钛)、ZnCl2(二氯化锌)、ZrCl4(四氯化锆)、AlCl3(三氯化铝)、SnCl4(四氯化锡)、(C2H5)2O·BF3(三氟化硼乙醚络合物)、(CH3)3SiOSO2CF3(三甲基甲硅烷基三氟甲磺酸酯)、(CH3)3SiCl(三甲基甲硅烷基氯化物)等。Among these metal compounds, TiCl 4 (titanium tetrachloride), ZnCl 2 (zinc dichloride), ZrCl 4 (zirconium tetrachloride), AlCl 3 (aluminum trichloride), SnCl 4 (tin tetrachloride) are more preferable. , (C 2 H 5 ) 2 O·BF 3 (boron trifluoride etherate), (CH 3 ) 3 SiOSO 2 CF 3 (trimethylsilyl triflate), (CH 3 ) 3 SiCl (trimethylsilyl chloride) and the like.
这些金属化合物可以单独使用,或者两种或更多种适当组合使用。These metal compounds may be used alone or in appropriate combination of two or more.
作为本发明的制备方法中使用的碱,可以列举如伯胺、仲胺、叔胺、吡啶类等。Examples of the base used in the production method of the present invention include primary amines, secondary amines, tertiary amines, pyridines and the like.
碱为伯胺时的具体例子有乙胺、丙胺、丁胺、苯胺、苄胺等。Specific examples when the base is a primary amine include ethylamine, propylamine, butylamine, aniline, benzylamine and the like.
碱为仲胺时的具体例子有二乙胺、二正丙基胺、二异丙基胺、甲基异丙基胺、乙基异丙基胺、二正丁基胺、二异丁基胺、二仲丁基胺、二叔丁基胺、N-甲基苯胺、N-乙基苯胺、吡咯烷、哌啶、吗啉、哌嗪、咪唑、二苄基胺等。Specific examples when the base is a secondary amine include diethylamine, di-n-propylamine, diisopropylamine, methylisopropylamine, ethylisopropylamine, di-n-butylamine, diisobutylamine , Di-sec-butylamine, di-tert-butylamine, N-methylaniline, N-ethylaniline, pyrrolidine, piperidine, morpholine, piperazine, imidazole, dibenzylamine, etc.
碱为叔胺时的具体例子有三甲胺、三乙胺、三丙胺、三异丙基胺、二异丙基甲胺、二异丙基乙胺、三正丁胺、三苄基胺、N-甲基哌啶、N-乙基哌啶、N-甲基吗啉、N-乙基吗啉、1,5-二氮杂双环[4.3.0]-5-壬烯、1,8-二氮杂双环[5.4.0]-7-十一碳烯、1,4-二氮杂双环[2.2.2]辛烷、N,N,N,N-四甲基乙二胺、N,N,N,N-四甲基-1,3-丙二胺、二甲基苯胺、二乙基苯胺等。Specific examples when the base is a tertiary amine include trimethylamine, triethylamine, tripropylamine, triisopropylamine, diisopropylmethylamine, diisopropylethylamine, tri-n-butylamine, tribenzylamine, N -Methylpiperidine, N-ethylpiperidine, N-methylmorpholine, N-ethylmorpholine, 1,5-diazabicyclo[4.3.0]-5-nonene, 1,8- Diazabicyclo[5.4.0]-7-undecene, 1,4-diazabicyclo[2.2.2]octane, N,N,N,N-tetramethylethylenediamine, N, N,N,N-tetramethyl-1,3-propanediamine, dimethylaniline, diethylaniline, etc.
碱为吡啶类时的具体例子有吡啶、α-甲基吡啶、β-甲基吡啶、γ-甲基吡啶、2,6-二甲基吡啶、2-乙基吡啶、3-乙基吡啶、4-乙基吡啶、N,N-二甲基氨基吡啶、喹啉、异喹啉等。When the base is pyridine, specific examples include pyridine, α-picoline, β-picoline, γ-picoline, 2,6-lutidine, 2-ethylpyridine, 3-ethylpyridine, 4-ethylpyridine, N,N-dimethylaminopyridine, quinoline, isoquinoline, etc.
这些碱中,例如,三乙胺、三正丁基胺、二异丙基乙胺、N-甲基哌啶、N-乙基哌啶、N-甲基吗啉、N-乙基吗啉、1,5-二氮杂双环[4.3.0]-5-壬烯、1,8-二氮杂双环[5.4.0]-7-十一碳烯、1,4-二氮杂双环[2.2.2]辛烷、N,N-二甲基氨基吡啶等,因其具有通用性、反应的选择性及收率也高,所以更加优选。Among these bases, for example, triethylamine, tri-n-butylamine, diisopropylethylamine, N-methylpiperidine, N-ethylpiperidine, N-methylmorpholine, N-ethylmorpholine , 1,5-diazabicyclo[4.3.0]-5-nonene, 1,8-diazabicyclo[5.4.0]-7-undecene, 1,4-diazabicyclo[ 2.2.2] Octane, N,N-dimethylaminopyridine, etc. are more preferable because of their versatility, high selectivity and high yield.
这些碱可以单独使用,也可以两种或更多种适当组合使用。本发明使用的碱可以直接使用市售品,根据需要也可以进行纯化。These bases may be used alone or in appropriate combination of two or more. The base used in the present invention can be used as it is from a commercial product, and can also be purified if necessary.
为实施本发明的制备方法,希望在氩气或氮气等惰性气氛下,在有机溶剂中进行。在这样的条件下,通过首先使通式[3]表示的重氮化合物与通式[4]表示的金属化合物及碱反应,然后使通式[2]表示的化合物与其反应,可以制备通式[1]表示的氮杂环丁酮化合物。In order to implement the preparation method of the present invention, it is desirable to carry out in an organic solvent under an inert atmosphere such as argon or nitrogen. Under such conditions, by first reacting the diazo compound represented by the general formula [3] with the metal compound represented by the general formula [4] and a base, and then reacting the compound represented by the general formula [2] with it, the general formula The azetidinone compound represented by [1].
作为反应中使用的有机溶剂,只要是不影响反应的惰性溶剂即可,可以列举如戊烷、己烷、庚烷等烃类溶剂、环己烷、甲基环己烷等脂环烃类溶剂、二氯甲烷、二氯乙烷、氯仿、二溴乙烷等卤代烃类溶剂、苯、氯苯、甲苯、二甲苯等芳香烃类溶剂、二乙醚、二异丙醚、四氢呋喃、二甲氧基乙烷、1,3-二氧戊烷、1,4-二氧六环等醚类溶剂、乙腈、丙腈等腈类溶剂、二甲基甲酰胺、二甲基乙酰胺等酰胺类溶剂等。As the organic solvent used in the reaction, as long as it is an inert solvent that does not affect the reaction, for example, hydrocarbon solvents such as pentane, hexane, and heptane, and alicyclic hydrocarbon solvents such as cyclohexane and methylcyclohexane , dichloromethane, dichloroethane, chloroform, dibromoethane and other halogenated hydrocarbon solvents, benzene, chlorobenzene, toluene, xylene and other aromatic hydrocarbon solvents, diethyl ether, diisopropyl ether, tetrahydrofuran, dimethyl Oxyethane, 1,3-dioxolane, 1,4-dioxane and other ether solvents, acetonitrile, propionitrile and other nitrile solvents, dimethylformamide, dimethylacetamide and other amides solvent etc.
这些溶剂可以单独使用,或者两种或更多种适当组合使用。These solvents may be used alone or in appropriate combination of two or more.
这些溶剂中的优选溶剂有卤代烃类溶剂、芳烃类溶剂、醚类溶剂等,其中从通用性、反应的选择性及收率高方面更优选二氯甲烷、甲苯、二甲苯、四氢呋喃等。Preferred solvents in these solvents include halogenated hydrocarbon solvents, aromatic hydrocarbon solvents, ether solvents, etc., among which dichloromethane, toluene, xylene, tetrahydrofuran, etc. are more preferred from the aspects of versatility, reaction selectivity and high yield.
这些溶剂的使用量没有特别的限制,但相对于通式[2]表示的化合物,通常在约1~50倍体积、优选约5~20倍体积的范围内。The amount of these solvents used is not particularly limited, but is usually within a range of about 1 to 50 times the volume, preferably about 5 to 20 times the volume, of the compound represented by the general formula [2].
反应温度通常采用-70~100℃左右、优选约-70~0℃左右的范围,通过在保持前述温度的同时进行约5分钟~5小时左右、优选约10分~3小时左右的反应,可以使反应平稳进行。The reaction temperature is usually in the range of about -70 to 100°C, preferably about -70 to 0°C, and the reaction can be carried out for about 5 minutes to 5 hours, preferably about 10 minutes to 3 hours, while maintaining the above temperature. Allow the reaction to proceed smoothly.
在本发明中,相对于1摩尔通式[2]表示的化合物,通式[3]表示的重氮化合物的使用量采用约0.5~5倍摩尔左右、优选约0.7~4倍摩尔左右的范围。In the present invention, the amount of the diazo compound represented by the general formula [3] is about 0.5 to 5 times moles, preferably about 0.7 to 4 times the moles, relative to 1 mole of the compound represented by the general formula [2]. .
在本发明中,相对于1摩尔通式[2]表示的化合物,通式[4]表示的金属化合物的使用量采用约0.5~2.5倍摩尔左右、优选约0.7~2倍摩尔左右的范围。In the present invention, the metal compound represented by general formula [4] is used in an amount of about 0.5 to 2.5 times moles, preferably about 0.7 to 2 times moles, relative to 1 mole of the compound represented by general formula [2].
本发明中,相对于1摩尔通式[2]表示的化合物,碱的使用量采用约1~8倍摩尔左右、优选约1.4~4倍摩尔左右。In the present invention, the base is used in an amount of about 1 to 8 times moles, preferably about 1.4 to 4 times moles, based on 1 mole of the compound represented by the general formula [2].
上述反应中R2为甲基等的烷基时,根据通式[3]表示的重氮化合物与通式[4]表示的金属化合物的种类和各种反应条件,生成的α-体和β-体的比例在某种程度上会有所不同,但目标β-体的含量通常为不低于约85%。In the above reaction, when R is an alkyl group such as a methyl group, the α-body and β-body formed according to the kind and various reaction conditions of the diazo compound represented by the general formula [3] and the metal compound represented by the general formula [4] The proportion of -body will vary to some extent, but the content of target β-body is usually not less than about 85%.
通过公知的后处理方法,即例如溶剂萃取、转溶、结晶、重结晶、各种色谱法等,可以由通过上述反应得到的反应液得到所需的氮杂环丁酮化合物。The desired azetidinone compound can be obtained from the reaction solution obtained by the above-mentioned reaction by known post-treatment methods such as solvent extraction, transsolution, crystallization, recrystallization, various chromatography and the like.
由通过本发明的制备方法得到的通式[1]表示的氮杂环丁酮化合物,通过公知的制备方法,可以容易地得到通式[B]From the azetidinone compound represented by the general formula [1] obtained by the production method of the present invention, the general formula [B] can be easily obtained by a known production method
(式中,R1表示烷基,R3与前同)表示的碳青霉烯类。(wherein, R 1 represents an alkyl group, and R 3 is the same as before) represented carbapenems.
实施例Example
以下通过实施例更详细地说明本发明,但本发明不受这些实施例的限制。The following examples illustrate the present invention in more detail, but the present invention is not limited by these examples.
另外,各实施例中的缩写如下所述:In addition, the abbreviations in each embodiment are as follows:
TBDMSO:叔丁基二甲基甲硅烷基氧基TBDMSO: tert-butyldimethylsilyloxy
OAc:乙酰氧基,PNB:对硝基苄基OAc: acetoxy, PNB: p-nitrobenzyl
实施例1(3S,4R)-3-[(R)-1-叔丁基二甲基甲硅烷基氧基乙基]-4-[(R)-1-甲基-3-重氮基-3-对硝基苄基氧羰基-2-氧代-丙基]-氮杂环丁烷-2-酮的制备Example 1 (3S, 4R)-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[(R)-1-methyl-3-diazo - Preparation of 3-p-nitrobenzyloxycarbonyl-2-oxo-propyl]-azetidin-2-one
在氮气氛下,将2-重氮基-3-氧代丁酸-对硝基苄酯2.22g(8.0mmol)的二氯甲烷溶液(15mL)冷却到-40℃,加入四氯化钛0.39mL(3.55mmol),在-40℃搅拌30分钟后,加入三丁胺1.81mL(7.57mmol),再在-40℃搅拌30分钟。然后,在该反应液中滴加(3R,4R)-4-乙酰氧基-3-[(R)-1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮574mg(2.0mmol)的二氯甲烷溶液(5mL),再在-40℃搅拌1小时。将反应混合物注入10%碳酸氢钠水溶液中停止反应,从有机层取样并水洗。用高效液相色谱分析的结果是,β∶α=95∶5。用无水硫酸镁干燥所得的有机层后,馏去溶剂,用色谱法纯化残渣,得到β-甲基衍生物(标题化合物)757mg(收率75%)。Under a nitrogen atmosphere, a dichloromethane solution (15 mL) of 2.22 g (8.0 mmol) of 2-diazo-3-oxobutanoic acid-p-nitrobenzyl ester was cooled to -40°C, and 0.39 g of titanium tetrachloride was added. mL (3.55 mmol), stirred at -40°C for 30 minutes, added 1.81 mL (7.57 mmol) of tributylamine, and stirred at -40°C for 30 minutes. Then, (3R,4R)-4-acetoxy-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-azetidine was added dropwise to the reaction solution A dichloromethane solution (5 mL) of 574 mg (2.0 mmol) of 2-ketone was stirred at -40°C for 1 hour. The reaction mixture was poured into 10% aqueous sodium bicarbonate solution to stop the reaction, and the organic layer was sampled and washed with water. As a result of analysis by high performance liquid chromatography, β:α=95:5. The obtained organic layer was dried over anhydrous magnesium sulfate, the solvent was distilled off, and the residue was purified by chromatography to obtain 757 mg (yield 75%) of the β-methyl derivative (the title compound).
该化合物的物性值与特开昭61-275284号记载的物性值一致。The physical property values of this compound corresponded to those described in JP-A-61-275284.
实施例2(3S,4R)-3-[(R)-1-叔丁基二甲基甲硅烷基氧基乙基]-4-[(R)-1-甲基-3-重氮基-3-对硝基苄基氧羰基-2-氧代-丙基]-氮杂环丁烷-2-酮的制备Example 2 (3S, 4R)-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[(R)-1-methyl-3-diazo - Preparation of 3-p-nitrobenzyloxycarbonyl-2-oxo-propyl]-azetidin-2-one
在氮气氛下,将2-重氮基-3-氧代丁酸-对硝基苄酯1.66g(6.0mmol)的二氯甲烷溶液(20mL)冷却到-40℃,加入四氯化钛0.66mL(6.0mmol),在-40℃搅拌30分钟后,加入N-乙基哌啶1.65mL(12.0mmol),再在-40℃搅拌30分钟。然后,在该反应液中滴加(3R,4R)-4-乙酰氧基-3-[(R)-1-叔丁基二甲基甲硅烷基氧基乙基]-氮杂环丁烷-2-酮1.72g(6.0mmol)的二氯甲烷溶液(5mL),再在-40℃搅拌1小时。在反应混合物中加入1M盐酸10mL,停止反应,从有机层取样并水洗。用高效液相色谱分析的结果是,β∶α=98∶2。用无水硫酸镁干燥所得的有机层后,馏去溶剂,用色谱法纯化残渣,得到β-甲基衍生物(标题化合物)2.09mg(收率69%)。Under nitrogen atmosphere, the dichloromethane solution (20mL) of 1.66g (6.0mmol) of 2-diazo-3-oxobutanoic acid-p-nitrobenzyl ester was cooled to -40°C, and titanium tetrachloride 0.66 mL (6.0 mmol), stirred at -40°C for 30 minutes, added 1.65 mL (12.0 mmol) of N-ethylpiperidine, and stirred at -40°C for 30 minutes. Then, (3R,4R)-4-acetoxy-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-azetidine was added dropwise to the reaction solution A dichloromethane solution (5 mL) of 1.72 g (6.0 mmol) of 2-ketone was stirred at -40°C for 1 hour. 10 mL of 1M hydrochloric acid was added to the reaction mixture to stop the reaction, and the organic layer was sampled and washed with water. As a result of analysis by high performance liquid chromatography, β:α=98:2. The obtained organic layer was dried over anhydrous magnesium sulfate, the solvent was distilled off, and the residue was purified by chromatography to obtain 2.09 mg (yield 69%) of a β-methyl derivative (the title compound).
实施例3、4Example 3, 4
除使用下表1所示的各种金属化合物代替实施例1中的四氯化钛外,按照与实施例1同样的方法进行反应和后处理,各自以下述的收率和生成比得到了与实施例1同样的氮杂环丁酮化合物。结果如表1所示。Except using the various metal compounds shown in the following table 1 to replace the titanium tetrachloride in embodiment 1, carry out reaction and aftertreatment according to the same method as embodiment 1, obtained with following yield and formation ratio respectively with The same azetidinone compound as in Example 1. The results are shown in Table 1.
表1
实施例5Example 5
除使用四氯化钛和三甲基甲硅烷基氯化物作为实施例1中的金属化合物以外,按照与实施例1同样的方式进行反应和后处理,得到了与实施例1同样的氮杂环丁酮化合物,收率68%,β-体∶α-体(生成比)=95∶5。Except using titanium tetrachloride and trimethylsilyl chloride as the metal compound in Example 1, the reaction and post-treatment were carried out in the same manner as in Example 1, and the same nitrogen heterocycle as in Example 1 was obtained. Butanone compound, yield 68%, β-body:α-body (formation ratio)=95:5.
实施例6Example 6
除将实施例1中的反应温度-40℃设定为5℃,使用三乙胺代替三丁胺作为碱以外,按照与实施例1同样的方式进行反应和后处理,得到了与实施例1同样的氮杂环丁酮化合物,收率69%,β-体∶α-体(生成比)=95∶5。Except that the reaction temperature-40°C in Example 1 is set as 5°C, and triethylamine is used instead of tributylamine as a base, the reaction and post-treatment are carried out in the same manner as in Example 1, and the same as in Example 1 is obtained. The yield of the same azetidinone compound was 69%, and the β-body:α-body (formation ratio)=95:5.
比较例1Comparative example 1
除不使用实施例1中的碱以外,按照与实施例1同样的方式进行反应时,完全没有得到目标产物。When the reaction was carried out in the same manner as in Example 1 except that the base in Example 1 was not used, the target product was not obtained at all.
实施例7~9Embodiment 7-9
除使用下表2所示的各种反应溶剂代替实施例1中的二氯甲烷以外,按照与实施例1同样的方式进行反应和后处理,各自以下述的收率和生成比得到了与实施例1同样的氮杂环丁酮化合物。结果如表2所示。Except using the various reaction solvents shown in the following table 2 to replace the dichloromethane in the embodiment 1, carry out the reaction and aftertreatment in the same manner as in the embodiment 1, respectively obtain the same as the embodiment with the following yield and formation ratio The same azetidinone compound as Example 1. The results are shown in Table 2.
表2
实施例10~13Examples 10-13
除在实施例1中使用将2-重氮基-3-氧代丁酸-对硝基苄酯(上述化学式中R=对硝基苄基的化合物)的对硝基苄基用下表3所示的各种取代基置换的化合物作为重氮化合物以外,按照与实施例1同样的方式进行反应和后处理,得到的各种氮杂环丁酮化合物中,以高选择性获得了β-甲基体。结果如表3所示。In addition to using the p-nitrobenzyl group of 2-diazo-3-oxobutanoic acid-p-nitrobenzyl ester (R=p-nitrobenzyl compound in the above chemical formula) in Example 1, the following table 3 The compounds substituted with the various substituents shown were reacted and post-treated in the same manner as in Example 1 except for the diazo compound. Among the obtained various azetidinone compounds, β- methyl body. The results are shown in Table 3.
表3
参考例1(1R,5R,6S)-对硝基苄基-2-二苯基磷酰基氧基-6-[(R)-1-羟基乙基]-1-甲基-碳青霉烯-3-羧酸酯的制备Reference Example 1 (1R, 5R, 6S)-p-nitrobenzyl-2-diphenylphosphoryloxy-6-[(R)-1-hydroxyethyl]-1-methyl-carbapenem - Preparation of 3-carboxylates
在氮气气流下,将(3S,4R)-3-[(R)-1-叔丁基二甲基甲硅烷基氧基乙基]-4-[(R)-1-甲基-3-重氮基-3-对硝基苄基氧羰基-2-氧代-丙基]-氮杂环丁烷-2-酮149.7g(314mmol)溶于甲醇750mL中后,加入2M盐酸水溶液44.5mL,在室温搅拌22.5小时。加入乙酸乙酯1.1L进行搅拌后,对有机层取样,并水洗。用无水硫酸镁干燥得到的有机层后,馏去溶剂,得到脱甲硅烷基产物107.6g。将所得到的脱甲硅烷基产物107.6g溶于乙酸乙酯1.1L中,加入辛酸铑(Rh2(Oct)4)0.65g,在50℃搅拌2.5小时。馏去溶剂,将得到的残渣溶于乙腈550mL中,冷却到-10℃后,顺序加入氯磷酸二苯酯77.8g、二异丙基乙胺39.2g,并在-10℃搅拌3小时。馏去溶剂,将得到的残渣溶于乙酸乙酯2.2L中。将得到的有机层水洗后,馏去溶剂,加入庚烷使结晶。过滤结晶并干燥,得到标题化合物137.9g。Under nitrogen flow, (3S, 4R)-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[(R)-1-methyl-3- Diazo-3-p-nitrobenzyloxycarbonyl-2-oxo-propyl]-azetidin-2-one 149.7g (314mmol) was dissolved in 750mL of methanol, and 44.5mL of 2M aqueous hydrochloric acid was added , stirred at room temperature for 22.5 hours. After adding 1.1 L of ethyl acetate and stirring, the organic layer was sampled and washed with water. After the obtained organic layer was dried over anhydrous magnesium sulfate, the solvent was distilled off to obtain 107.6 g of a desilylated product. 107.6 g of the obtained desilylated product was dissolved in 1.1 L of ethyl acetate, 0.65 g of rhodium octanoate (Rh 2 (Oct) 4 ) was added, and the mixture was stirred at 50° C. for 2.5 hours. The solvent was distilled off, and the obtained residue was dissolved in 550 mL of acetonitrile, cooled to -10°C, 77.8 g of diphenyl chlorophosphate and 39.2 g of diisopropylethylamine were sequentially added thereto, followed by stirring at -10°C for 3 hours. The solvent was distilled off, and the obtained residue was dissolved in 2.2 L of ethyl acetate. After the obtained organic layer was washed with water, the solvent was distilled off, and heptane was added to crystallize. The crystals were filtered and dried to obtain 137.9 g of the title compound.
该化合物的物性值与Heterocycles,21卷,29-40页(1984)和特开平6-321946号记载的该化合物的物性值一致。The physical property values of this compound are consistent with the physical property values of this compound described in Heterocycles, Vol. 21, pp. 29-40 (1984) and JP-A-6-321946.
工业实用性Industrial Applicability
本发明提供在温和条件下、工序少、收率好、且选择性地制备氮杂环丁酮化合物的制备方法,其中,氮杂环丁酮化合物是用于工业上制备1β-甲基碳青霉烯衍生物的重要合成中间体,并且1β-甲基碳青霉烯衍生物适合用于制备用作抗菌物质的碳青霉烯类抗生物质。本发明在该方面取得了显著的效果。The invention provides a method for selectively preparing azetidinone compounds under mild conditions with fewer steps and good yields, wherein the azetidinone compounds are used for the industrial preparation of 1β-methylcarbocyanine It is an important synthetic intermediate of mycocene derivatives, and 1β-methyl carbapenem derivatives are suitable for preparing carbapenem antibiotics used as antibacterial substances. The present invention achieves remarkable effects in this respect.
Claims (14)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP82560/2002 | 2002-03-25 | ||
| JP2002082560A JP2003277390A (en) | 2002-03-25 | 2002-03-25 | Method for producing azetidinone compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1610663A true CN1610663A (en) | 2005-04-27 |
| CN1277819C CN1277819C (en) | 2006-10-04 |
Family
ID=28449147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB03801808XA Expired - Fee Related CN1277819C (en) | 2002-03-25 | 2003-02-17 | Process for producing azetidinone compounds |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2003277390A (en) |
| KR (1) | KR20040095198A (en) |
| CN (1) | CN1277819C (en) |
| AU (1) | AU2003211227A1 (en) |
| WO (1) | WO2003080571A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101891665B (en) * | 2009-05-22 | 2013-02-06 | 上海医药工业研究院 | (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method |
| CN102936217A (en) * | 2012-11-08 | 2013-02-20 | 浙江新东港药业股份有限公司 | Preparation method of intermediate for penem |
| CN103553995A (en) * | 2013-11-13 | 2014-02-05 | 凯莱英医药集团(天津)股份有限公司 | Method for preparing penem antibiotic midbody |
| WO2015070394A1 (en) * | 2013-11-13 | 2015-05-21 | 凯莱英医药集团(天津)股份有限公司 | Method for preparing penem antibiotic intermediate |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8841444B2 (en) | 2008-07-30 | 2014-09-23 | Ranbaxy Laboratories Limited | Process for the preparation of carbapenem compounds |
| WO2011048583A1 (en) | 2009-10-23 | 2011-04-28 | Ranbaxy Laboratories Limited | Process for the preparation of carbapenem compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3509769A1 (en) * | 1985-03-19 | 1986-09-25 | Bayer Ag, 5090 Leverkusen | METHOD FOR PRODUCING CARBAPENE INTERMEDIATE PRODUCTS |
| DE3617626A1 (en) * | 1986-05-26 | 1987-12-03 | Bayer Ag | SUBSTITUTED 6-HYDROXYMETHYL CARBAPENEM ANTIBIOTICS, METHOD FOR THEIR PRODUCTION AND THEIR USE |
| NZ234411A (en) * | 1989-07-18 | 1991-05-28 | Merck & Co Inc | Preparation of 2-diazo-3-silyloxy-3-butenoate esters |
| GB9124850D0 (en) * | 1991-11-22 | 1992-01-15 | Harding Paul F | Assembly comprising clip device |
| JP3787819B2 (en) * | 1994-07-14 | 2006-06-21 | 日本曹達株式会社 | Azetidinone compound and method for producing the same |
| EP1071685A4 (en) * | 1998-04-16 | 2001-07-18 | Merck & Co Inc | PREPARATION OF INTERMEDIATE PRODUCTS OF TITANIUM CATALYZED CARBAPENEMS |
| JP4294124B2 (en) * | 1998-06-23 | 2009-07-08 | 日本曹達株式会社 | Method for producing azetidinone derivative |
-
2002
- 2002-03-25 JP JP2002082560A patent/JP2003277390A/en active Pending
-
2003
- 2003-02-17 KR KR10-2004-7008611A patent/KR20040095198A/en not_active Withdrawn
- 2003-02-17 WO PCT/JP2003/001615 patent/WO2003080571A1/en not_active Ceased
- 2003-02-17 AU AU2003211227A patent/AU2003211227A1/en not_active Abandoned
- 2003-02-17 CN CNB03801808XA patent/CN1277819C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101891665B (en) * | 2009-05-22 | 2013-02-06 | 上海医药工业研究院 | (3S,4S)-4-acetyl-3-((R)-1-hydroxyethyl)-2-azetidinone and its preparation method |
| CN102936217A (en) * | 2012-11-08 | 2013-02-20 | 浙江新东港药业股份有限公司 | Preparation method of intermediate for penem |
| CN103553995A (en) * | 2013-11-13 | 2014-02-05 | 凯莱英医药集团(天津)股份有限公司 | Method for preparing penem antibiotic midbody |
| WO2015070394A1 (en) * | 2013-11-13 | 2015-05-21 | 凯莱英医药集团(天津)股份有限公司 | Method for preparing penem antibiotic intermediate |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20040095198A (en) | 2004-11-12 |
| WO2003080571A1 (en) | 2003-10-02 |
| AU2003211227A1 (en) | 2003-10-08 |
| CN1277819C (en) | 2006-10-04 |
| JP2003277390A (en) | 2003-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1194980C (en) | Phosphonocephem derivatives, their preparation and use | |
| CN1117965A (en) | Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines | |
| CN1277819C (en) | Process for producing azetidinone compounds | |
| CN1036996C (en) | Method for preparing 3S,4R-N-oxalyl-3-ethyl-4-[1R-oxo-3S-thiolanylthio (thiocarbonyl)-thio]-2-azetidinones | |
| CN1065866A (en) | The prodrug esters of phenol 2-piperidino-(1-position only)-1-alkanol | |
| CN1956951A (en) | Method for producing diphenyl azetidinone derivatives | |
| CN1034329C (en) | Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them | |
| JPH0881439A (en) | Azetidinone compound and its production | |
| CN1247581C (en) | Production method of carbapenem antibacterial agent | |
| CN100347179C (en) | Novel synthetic intermediate of carbapenem compound for oral administration and its production method | |
| CN1093861C (en) | 1-methylcarbapenem derivatives | |
| US20030191106A1 (en) | Intermediate of carbapenem antibiotics and process for the preparation thereof | |
| WO2004043961A1 (en) | Process for producing carbapenem compound for oral administration | |
| KR100886347B1 (en) | Stereoselective Manufacturing Method of 4-BM using Chiral Adjuvant | |
| CN1934078A (en) | Stereoselective synthesis of vitamin D analogues | |
| CN1041944A (en) | The preparation method of penem | |
| KR100959027B1 (en) | Method for preparing penem intermediate using zinc compound as cocatalyst | |
| CN1653061A (en) | The preparation method of quinolone carboxylic acid derivative | |
| WO2017168438A1 (en) | Process for preparing pure allyl protected keto derivative | |
| JP4213229B2 (en) | Method for producing azetidinone derivative | |
| JPH0725848A (en) | Production of 4-substituted azetidinone derivative | |
| JP2018095561A (en) | Method for producing diphenyl azetidine derivative | |
| CN1805968A (en) | Crystalline carbapenem intermediate | |
| CN1556109A (en) | 2-Benzene carboxylate penem compound and its preparation method and application | |
| JPWO2003089432A1 (en) | Method for producing carbapenem derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |